OncoZenge är ett svensk läkemedelsbolag som utvecklar en ny behandling för effektiv smärtlindring hos patienter som lider av oral smärta orsakad av strålningsbehandling och kemoterapi mot cancer.
Bolagets produktkandidat är BupiZenge®.
Company Details
- Employees
- 5
- Address
- Gustavslundsvägen 12, 5,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.oncozenge.se
- Keywords
- Oral pain and Oral Pain Relief.
- HQ
- Alvik, Stockholm County
Oncozenge Ab Questions
Oncozenge Ab's website is http://www.oncozenge.se
Oncozenge Ab's LinkedIn profile is https://se.linkedin.com/company/oncozenge-ab
Oncozenge Ab has
5 employees.
View email and phone details for 5
employees at Oncozenge Ab.
Oncozenge Ab's industry is
Pharmaceutical Manufacturing
Oncozenge Ab's top competitors are
Abiogen Pharma S.p.a.,
Molteni Farmaceutici,
Melius Pharma,
Meribel Pharma Solutions,
Alzecure Pharma,
Northx Biologics,
Avernus Pharma,
Bioarctic,
Saniona,
Diamyd Medical.
Oncozenge Ab's categories are Pharmaceutical Manufacturing
